AIMEI HEALTH TECHNOLOGY CO., LTD

AFJK ·Industrials, Specialty Business Services, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024
Operating Activities
Net Income $1.1M $2.6M
Depreciation & Amortization
Depreciation
Amortization
Stock-Based Compensation
Net Cash from Operating Activities $-565.1K $-672.3K
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities $63.6M $-277.7K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $-63.0M $397.5K
Net Change in Cash $-25.3K $-552.5K
Free Cash Flow